LIVN | LivaNova PLC Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	47.03 - 49.31
52 Week Range	43.15 - 64.48
Beta	1.05
Implied Volatility	49.11%
IV Rank	43.21%
Day's Volume	1,136,127
Average Volume	476,300
Shares Outstanding	54,300,800
Market Cap	2,584,175,072
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2015-10-19

Valuation
Profitability
Growth
Health
P/E Ratio	110.67
Forward P/E Ratio	N/A
EPS	0.43
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	2,900
Country	UK
Website	LIVN

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.

LIVN's peers: AHCO, APYX, ATEC, AVNS, AXDX, AXGN, BIO-B, MODD, BRKR, XTNT, CLPT, SMLR, CNMD, CTKB, CTSO, CUTR, CVRX, ELMD, DCTH, ESTA, FNA, GKOS, GMED, HYPR, IRMD, IRTC, ITGR, KIDS, LUNG, SIBN, NPCE, OFIX, HSKA, NUVA, LUCD, MASI, MOVE, NVCR, NVNO, NVRO, PEN, PRCT, PROF, QDEL, RPID, SNN, SRDX, STE, TCMD, TMCI, NXL, CATX

*Chart delayed

Analyzing fundamentals for LIVN we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is unacceptably poor, Growth is good and Health is passable. For more detailed analysis please see LIVN Fundamentals page.

Watching at LIVN technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on LIVN Technicals page.